Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
5.45
-0.28 (-4.89%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cryo-Cell International Market Cap

Cryo-Cell International has a market cap or net worth of $45.42 million as of April 25, 2025. Its market cap has decreased by -26.50% in one year.

Market Cap
45.42M
Enterprise Value
55.80M
1-Year Change
-26.50%
Ranking
Category
Stock Price
$5.45

Market Cap Chart

Since December 1, 1998, Cryo-Cell International's market cap has increased from $21.70M to $45.42M, an increase of 109.32%. That is a compound annual growth rate of 2.84%.

History

DateMarket Cap% Change
Apr 25, 202545.40M-23.95%
Dec 31, 202459.70M25.42%
Dec 29, 202347.60M32.22%
Dec 30, 202236.00M-63.60%
Dec 31, 202198.90M70.22%
Dec 31, 202058.10M4.50%
Dec 31, 201955.60M-4.96%
Dec 31, 201858.50M-14.85%
Dec 29, 201768.70M121.61%
Dec 30, 201631.00M6.90%
Dec 31, 201529.00M21.34%
Dec 31, 201423.90M20.10%
Dec 31, 201319.90M-14.96%
Dec 31, 201223.40M-0.43%
Dec 30, 201123.50M-16.67%
Dec 31, 201028.20M34.93%
Dec 31, 200920.90M326.53%
Dec 31, 20084.90M-46.74%
Dec 31, 20079.20M-65.28%
Dec 29, 200626.50M-32.91%
Dec 30, 200539.50M-19.22%
Dec 31, 200448.90M431.52%
Dec 31, 20039.20M-50.27%
Dec 31, 200218.50M-65.80%
Dec 31, 200154.10M132.19%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings